Photo by lamoune from unsplash
A 12‐year‐old boy presented with a 2‐week history of persistent pruritic edematous plaques one day after he received the first dose of the BNT162b2 COVID‐19 mRNA vaccine. A skin biopsy… Click to show full abstract
A 12‐year‐old boy presented with a 2‐week history of persistent pruritic edematous plaques one day after he received the first dose of the BNT162b2 COVID‐19 mRNA vaccine. A skin biopsy showed urticarial dermatitis with tissue eosinophilia consistent with a diagnosis of vaccine‐associated eosinophilic cellulitis, with polyethylene glycol as a potential trigger.
Keywords:
bnt162b2 covid;
cellulitis response;
eosinophilic cellulitis
Journal Title: Pediatric Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatric Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!